Pitango HealthTech Fund I, L.P. is a venture capital fund based in Herzliya, Israel. According to its most recent Form D, filed May 1, 2020, it has sold $131,500,000 of interests to 25 investors since its first sale in May 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include General Partner Pitango H.T. Fund I, LP; General Partner of the General Partner Pitango GP Health Holdings Ltd.
- Total raised
- $131,500,000Cumulative sales reported on Form D
- Investors
- 25
- First sale
- May 7, 2019
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- General Partner Pitango H.T. Fund I, LP; General Partner of the General Partner Pitango GP Health Holdings Ltd
- Latest Form D
- May 1, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| May 1, 2020 | Form D/A (amendment) | $131,500,000 | 25 | SEC.gov ↗ |
| May 2, 2019 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on May 2, 2019. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| The Russell Berrie Foundation | NJ | $1,919,407 | fair market value | Dec 31, 2024 |
| The Klarman Family Foundation | MA | $1,599,506 | fair market value | Dec 31, 2024 |
2 private foundations listed this fund by name among the investments on their IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about Pitango HealthTech Fund I, L.P.
What is the minimum investment for Pitango HealthTech Fund I, L.P.?
Pitango HealthTech Fund I, L.P.'s latest Form D, filed May 1, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Pitango HealthTech Fund I, L.P.?
Pitango HealthTech Fund I, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Pitango HealthTech Fund I, L.P. raised?
Pitango HealthTech Fund I, L.P. reports $131,500,000 sold from 25 investors on its Form D filed May 1, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is Pitango HealthTech Fund I, L.P. based?
Pitango HealthTech Fund I, L.P. is based in Herzliya, Israel.
When did Pitango HealthTech Fund I, L.P. launch?
Pitango HealthTech Fund I, L.P. reports its first sale in May 2019.
Size compared with every venture capital fund
Raised more than 95% of the 128 venture capital funds based in Israel, and more than 98% of all 14,876 that report sales.